ARIAD PHARMACEUTICALS INC General and Administrative Expense
ARIAD PHARMACEUTICALS INC reported General and Administrative Expense of $60.91 million for the 12-month period ending 2012-12-31, per its 10-K filed 2013-03-01.
Discontinued › Expense Statement › Operating Expenses
us-gaap:GeneralAndAdministrativeExpense · last filed 2013-03-01
- ARIAD PHARMACEUTICALS INC general and administrative expense for the quarter ending 2012-12-31 was $22.91M, a 225.22% increase year-over-year.
- ARIAD PHARMACEUTICALS INC general and administrative expense for the quarter ending 2012-09-30 was $14.48M, a 128.82% increase year-over-year.
- ARIAD PHARMACEUTICALS INC general and administrative expense for the quarter ending 2012-06-30 was $12.22M, a 98.70% increase year-over-year.
- ARIAD PHARMACEUTICALS INC general and administrative expense for the quarter ending 2012-03-31 was $11.29M, a 132.55% increase year-over-year.
- ARIAD PHARMACEUTICALS INC general and administrative expense for fiscal 2012 was $60.91M, a 149.83% increase from fiscal 2011.
- ARIAD PHARMACEUTICALS INC general and administrative expense for fiscal 2011 was $24.38M, a 51.48% increase from fiscal 2010.
- ARIAD PHARMACEUTICALS INC general and administrative expense for fiscal 2010 was $16.09M, a 4.70% decline from fiscal 2009.
- ARIAD PHARMACEUTICALS INC general and administrative expense for fiscal 2009 was $16.89M.
| Period end | General and Administrative Expense 3 month | General and Administrative Expense 6 month | General and Administrative Expense 9 month | General and Administrative Expense 12 month |
|---|---|---|---|---|
| 2012-12-31 | $22.91M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-01 | $37.40M derived: sum of 2 quarters · filed 2013-03-01 | $49.62M derived: sum of 3 quarters · filed 2013-03-01 | $60.91M 10-K · filed 2013-03-01 |
| 2012-09-30 | $14.48M 10-Q · filed 2012-11-09 | $26.71M derived: sum of 2 quarters · filed 2012-11-09 | $37.99M 10-Q · filed 2012-11-09 | $45.04M derived: sum of 4 quarters · filed 2013-03-01 |
| 2012-06-30 | $12.22M 10-Q · filed 2012-08-09 | $23.51M 10-Q · filed 2012-08-09 | $30.56M derived: sum of 3 quarters · filed 2013-03-01 | $36.89M derived: sum of 4 quarters · filed 2013-03-01 |
| 2012-03-31 | $11.29M 10-Q · filed 2012-05-09 | $18.33M derived: sum of 2 quarters · filed 2013-03-01 | $24.66M derived: sum of 3 quarters · filed 2013-03-01 | $30.82M derived: sum of 4 quarters · filed 2013-03-01 |
| 2011-12-31 | $7.05M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-01 | $13.38M derived: sum of 2 quarters · filed 2013-03-01 | $19.53M derived: sum of 3 quarters · filed 2013-03-01 | $24.38M 10-K · filed 2013-03-01 |
| 2011-09-30 | $6.33M 10-Q · filed 2012-11-09 | $12.48M derived: sum of 2 quarters · filed 2012-11-09 | $17.33M 10-Q · filed 2012-11-09 | $21.18M derived: sum of 4 quarters · filed 2013-03-01 |
| 2011-06-30 | $6.15M 10-Q · filed 2012-08-09 | $11.01M 10-Q · filed 2012-08-09 | $14.86M derived: sum of 3 quarters · filed 2013-03-01 | $18.53M derived: sum of 4 quarters · filed 2013-03-01 |
| 2011-03-31 | $4.85M 10-Q · filed 2012-05-09 | $8.70M derived: sum of 2 quarters · filed 2013-03-01 | $12.37M derived: sum of 3 quarters · filed 2013-03-01 | $16.38M derived: sum of 4 quarters · filed 2013-03-01 |
| 2010-12-31 | $3.85M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-01 | $7.52M derived: sum of 2 quarters · filed 2013-03-01 | $11.52M derived: sum of 3 quarters · filed 2013-03-01 | $16.09M 10-K · filed 2013-03-01 |
| 2010-09-30 | $3.67M 10-Q · filed 2011-11-07 | $7.67M derived: sum of 2 quarters · filed 2011-11-07 | $12.24M 10-Q · filed 2011-11-07 | |
| 2010-06-30 | $4.00M 10-Q · filed 2011-08-09 | $8.57M 10-Q · filed 2011-08-09 | ||
| 2009-12-31 | $16.89M 10-K/A · filed 2012-03-30 |